VTYX - Ventyx Biosciences Chief Scientific Officer Acquires 10000 Shares After Exercising Company Stock Options | Benzinga
John Nuss, Chief Scientific Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large exercise of company stock options on October 4, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Nuss, Chief Scientific Officer at Ventyx Biosciences, a company in the Health Care sector, just exercised stock options worth 10,000 shares of VTYX stock with an exercise price of $3.35.
Ventyx Biosciences shares are trading up 0.39% at $28.51 at the time of this writing on Thursday morning. Since the current price is $28.51, this makes Nuss's 10,000 shares worth $285,100.